What's new in i.v. immunoglobulin therapy and pemphigus : High-dose i.v. immunoglobulin therapy and its mode of action for treatment of pemphigus
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-03-01
著者
-
Aoyama Yumi
Department Of Dermatology Gifu University Graduate School Of Medicine
-
Aoyama Yumi
Department Of Dermatology Okayama University Graduate School Of Medicine Dentistry And Pharmaceutica
関連論文
- Three essential conditions to cultivate physician scientists
- A prospective analysis of anti-desmoglein antibody profiles in patients with rheumatoid arthritis treated with thiol compounds
- p120 catenin is associated with desmogleins when desmosomes are assembled in high-Ca^ medium but not when disassembled in low-Ca^ medium in DJM-1 cells
- No activation of urokinase plasminogen activator by anti-desmoglein 3 monoclonal IgG antibodies in cultured human keratinocytes
- Pemphigus vulgaris-IgG reduces the desmoglein 3/desmocollin 3 ratio on the cell surface in cultured keratinocytes as revealed by double-staining immunoelectron microscopy
- Scraped-Wounding Causes Activation and Association of C-Src Tyrosine Kinase with Microtubules in Cultured Keratinocytes
- Surfactant Protein D (SP-D) and Systemic Scleroderma (SSc)
- New non-invasive method for evaluation of the stratum corneum structure in diseases with abnormal keratinization by immunofluorescence microscopy of desmoglein 1 distribution in tape-stripped samples
- What's new in i.v. immunoglobulin therapy and pemphigus : High-dose i.v. immunoglobulin therapy and its mode of action for treatment of pemphigus
- Two cases of recessive dystrophic epidermolysis bullosa diagnosed as severe generalized
- Human leukocyte antigen genotypes and antibody profiles associated with familial pemphigus in Japanese